Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 Activity

REFERENCES

• Agkur , S. S. , Ozturk , P. , Sozmen , E. Y. , Delen , Y. , Tanyalcin , T. and Ege , B. 1999 . Paroxonase and acetylcholinesterase activities in humans exposed to organophosphate compounds . J. Toxicol. Environ. Health A , 58 : 469 – 474 .
   PubMed Web of Science ®Google Scholar
• Au , W. , Sierra-Torres , C. , Cajas-Salazar , N. , Shipp , B. and Legator , M. 1999 . Cytogenic effects from exposure to mixed pesticides and the influence from genetic susceptibility . Environ. Health Perspect. , 107 : 501 – 505 .
   PubMed Web of Science ®Google Scholar
• Aubo , C. , Senti , M. , Marrugat , J. , Tomas , M. , Vila , J. , Sala , J. and Masia , R. 2000 . Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus . Eur. Heart J. , 21 : 33 – 38 .
   PubMed Web of Science ®Google Scholar
• Augustinsson , K. and Barr , M. 1963 . Age variation in plasma arylesterase activity in children . Clin. Chem. Acta , 8 : 568 – 573 .
   PubMed Web of Science ®Google Scholar
• Augustinsson , K. and Henrickson , B. 1965 . Some factors regulating normal arylesterase activity of blood plasma in rats . Acta Physiol. Scand. , 64 : 418 – 426 .
   PubMedGoogle Scholar
• Augustinsson , K. and Henrickson , B. 1969 . Stress-induced alterations in arylesterase activity in the rat . Biochem. Pharmacol. , 19 : 21 – 27 .
   Google Scholar
• Akhmedova , S. , Yakimovsky , A. and Schwartz , E. 2001 . Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease . J. Neurol. Sci. , 184 : 179 – 182 .
   PubMed Web of Science ®Google Scholar
• Akhmedova , S. , Anismov , S. , Yakimovsky , A. and Schwartz , E. 1999 . Gln-Arg 191 polymorphism of paraoxonase and Parkinson's disease . Hum. Hered. , 49 : 178 – 179 .
   PubMed Web of Science ®Google Scholar
• Allebrandt , K. , Souza , R. and Chautard-Freire-Maia , E. 2002 . Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians . Toxicol. Appl. Pharmacol. , 180 : 151 – 156 .
   PubMed Web of Science ®Google Scholar
• Antikainen , M. , Murtomaki , S. , Syvanne , M. , Pahlman , R. , Tahvanainen , E. , Jauhiainen , M. , Frick , M. and Ehnholm , C. 1996 . The Gln-Arg192 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns . J. Clin. Invest. , 99 : 883 – 885 .
   Google Scholar
• Atterberry , T. , Burnett , W. and Chambers , J. 1997 . Age-related differences in parathion and chlorpyrifos toxicity in male rats: Target and non-target esterase sensitivity and cytochrome P450-mediated metabolism . Toxicol. Appl. Pharmacol. , 147 : 411 – 418 .
   PubMed Web of Science ®Google Scholar
• Aviram , M. and Fuhrman , B. 2002 . Wine flavonoids protect against LDL oxidation and atherosclerosis . Ann. NY Acad. Sci. , 957 : 146 – 161 .
   PubMed Web of Science ®Google Scholar
• Aviram , M. , Billecke , S. , Sorenson , R. , Bisgaier , C. , Newton , R. , Rosenblat , M. , Erogul , J. , Hsu , C. , Dunlop , C. and La Du , C. 1998a . Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R . Arterioscler. Thomb. Vasc. Biol. , 18 : 1617 – 1624 .
   PubMed Web of Science ®Google Scholar
• Aviram , M. , Rosenblat , M. , Bisgaier , C. , Newton , R. , Primo-Parmo , S. and La Du , B. 1998b . Paraoxonase inhibits high density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase . J. Clin. Invest. , 101 : 1581 – 1590 .
   PubMed Web of Science ®Google Scholar
• Aviram , M. , Dornfeld , L. , Rosenblat , M. , Volkova , N. , Kaplan , M. , Coleman , R. , Hayek , T. , Presser , D. and Fuhrman , B. 2000 . Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice . Am. J. Clin. Nutr. , 71 : 1062 – 1076 .
   PubMed Web of Science ®Google Scholar
• Aynacioglu , A. , Cascorbi , I. , Mrozikiewicz , P. , Nacak , M. , Tapayigit , E. and Roots , I. 1999 . Paraoxonase 1 mutations in a Turkish population . Toxicol. Appl. Pharmacol. , 157 : 174 – 177 .
   PubMed Web of Science ®Google Scholar
• Aynacioglu , A. and Kepekci , Y. 2000 . The human paraoxonase Gln-Arg192 (Q/R) polymorphism in Turkish patients with coronary artery disease . Int. J. Cardiol. , 74 : 33 – 37 .
   PubMed Web of Science ®Google Scholar
• Balcerzyk , A. , Zak , I. and Krauze , J. 2007 . Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease . Arch. Med. Res. , 38 : 545 – 550 .
   PubMed Web of Science ®Google Scholar
• Barbieri , M. , Bonafe , M. , Marfella , R. , Ragno , E. , Giugliano , D. , Franceschi , C. and Paolisso , G. 2002 . LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in health subjects . J. Clin. Endocrinol. Metab. , 87 : 222 – 225 .
   PubMed Web of Science ®Google Scholar
• Baum , L. , Ng , H. K. , Woo , K. S. , Tomlinson , B. , Rainer , T. H. , Chen , X. , Cheung , W. S. , Chan , D. K. , Thomas , G. N. , Tong , C. S. and Wong , K. S. 2006 . Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk . Clin. Biochem. , 39 : 191 – 195 .
   PubMed Web of Science ®Google Scholar
• Benmoyal-Segal , L. , Vander , T. , Shifman , S. , Bryk , B. , Ebstein , R. P. , Marcus , E. L. , Stessman , J. , Darvasi , A. , Herishanu , Y. , Friedman , A. and Soreq , H. 2005 . Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease . FASEB J. , 19 : 452 – 454 .
   PubMed Web of Science ®Google Scholar
• Berkowitz , G. S. , Wetmur , J. G. , Birman-Deych , E. , Obel , J. , Lapinski , R. H. , Godbold , J. H. , Holzman , J. R. and Wolff , M. S. 2004 . In utero pesticide exposure, maternal paraoxonase activity and head circumference . Environ. Health Perspect. , 112 : 388 – 391 .
   PubMed Web of Science ®Google Scholar
• Bielicki , J. , Knoff , L. , Tribble , D. and Forte , T. 2001 . Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure . Atheroslcerosis , 155 : 71 – 78 .
   PubMed Web of Science ®Google Scholar
• Blatter-Garin , M. , James , R. , Messmer , S. , Barja , F. and Pometta , D. 1993 . Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45: Identity of K-45 with paraoxonase . Eur. J. Biochem. , 211 : 871 – 879 .
   PubMedGoogle Scholar
• Blatter-Garin , M. , James , R. , Dussoix , P. , Blanche , H. , Passa , P. , Froguel , P. and Ruiz , J. 1997 . Paraoxonase polymorphism Met-Leu55 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes . J. Clin. Invest. , 99 : 62 – 66 .
   PubMed Web of Science ®Google Scholar
• Brooks , A. , Chadwick , C. , Gelbard , H. , Cory-Slechta , D. and Federoff , H. 1999 . Paraquat elicited neurobehavioral syndrome caused by dopaminergic neurone . Brain Res. , 823 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Broomfield , C. A. and Ford , K. W. . Hydrolysis of nerve agents by plasma enzymes . ACS Conference Proceedings Series: Cholinesterases structure, function mechanism, genetics, and cell biology . Washinton, DC. American Chemical Society, number 307 .
   Google Scholar
• Brophy , V. , Jarvik , G. , Richter , R. , Rozek , L. , Schellenberg , G. and Furlong , C. 2000 . Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype . Pharmacogenetics , 10 : 453 – 460 .
   PubMedGoogle Scholar
• Brophy , V. , Hastings , M. , Clendenning , J. , Richter , R. , Jarvik , G. and Furlong , C. 2001a . Polymorphisms in the human paraoxonase (PON1) promoter . Pharmacogenetics , 11 : 77 – 84 .
   PubMedGoogle Scholar
• Brophy , V. , Jampsa , R. , Clendenning , J. , McKinstry , L. , Jarvik , G. and Furlong , C. 2001b . Effects of 5’ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression . Am. J. Hum. Genet. , 68 : 1428 – 1436 .
   PubMed Web of Science ®Google Scholar
• Bryk , B. , Ben Moyal-Segal , L. , Podoly , E. , Livnah , O. , Eisenkraft , A. , Luria , S. , Cohen , A. , Yehezkelli , Y. , Hourvitz , A. and Soreq , H. 2005 . Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities . J. Neurochem. , 92 : 1216 – 1227 .
   PubMed Web of Science ®Google Scholar
• Butler , A. and Murray , M. 1997 . Biotransformation of parathion in human liver: Participation of CYP3A4 and its inactivation during microsomal parathion oxidation . J. Pharmacol. Exp. Ther. , 280 : 966 – 973 .
   PubMed Web of Science ®Google Scholar
• California Environmental Protection Agency . Report for the application and ambient air monitoring of chlorpyrifos (and the oxon analogue) in Tulare County during spring/summer, 1996 . State of California, California Environmental Protection Agency, Air Resources Board. Project No. C96-0421 (Ambient) C96–040 (Application) . 1998 .
   Google Scholar
• Carlson , C. S. , Heagerty , P. J. , Hatsukami , T. S. , Richter , R. J. , Ranchalis , J. , Lewis , J. , Bacus , T. J. , McKinstry , L. A. , Schellenberg , G. D. , Rieder , M. , Nickerson , D. , Furlong , C. E. , Chait , A. and Jarvik , G. P. 2006 . TagSNP analyses of the PON gene cluster: Effects on PON1 activity, LDL oxidative susceptibility, and vascular disease . J. Lipid Res. , 47 : 1014 – 1024 .
   PubMed Web of Science ®Google Scholar
• Carpintero , A. , Sanchez-Martin , M. , Cabezas-Delamare , J. and Cabezas , J. 1996 . Variation in serum arylesterase, beta-glucuronidase, cathepsin L and plasminogen activators during pregnancy . Clin. Chim. Acta , 225 : 153 – 164 .
   Google Scholar
• Cascorbi , I. , Laule , M. , Mrozikiewicz , PM. , Mrozikiewicz , A. , Andel , C. , Baumann , G. , Roots , I. and Strangl , K. 1999 . Mutations in the human paroxonase 1 gene: Frequencies, allelic linkages, and association with coronary artery disease . Pharmacogenetics , 9 : 755 – 761 .
   PubMedGoogle Scholar
• Cellini , E. , Tedde , A. , Bagnoli , S. , Nacmias , B. , Piacentini , S. , Bessi , V. , Bracco , L. and Sorbi , S. 2006 . Association analysis of the paraoxonase-1 gene with Alzheimer's disease . Neurosci. Lett. , 408 : 199 – 202 .
   PubMed Web of Science ®Google Scholar
• Chemnitius , J. , Winkel , H. , Meyer , I. , Schirrmacher , K. , Armstrong , V. , Kreuzer , H. and Zech , R. 1998 . Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease . Med. Klin. , 93 : 135 – 137 .
   Google Scholar
• Chen , J. , Kumar , M. , Chan , W. , Berkowitz , G. and Wetmur , J. G. 2003 . Increased influence of genetic variation on PON1 activity in neonates . Environ. Health Perspect. , 111 : 1403 – 1409 .
   PubMed Web of Science ®Google Scholar
• Chen , J. , Chan , W. , Wallenstein , S. , Berkowitz , G. and Wetmur , JG. 2005 . Haplotype–phenotype relationships of paraoxonase-1 . Cancer Epidemiol. Biomarkers Prev. , 14 : 731 – 734 .
   PubMed Web of Science ®Google Scholar
• Cherry , N. , Mackness , M. , Durrington , P. , Povey , A. , Dippnall , M. , Smith , T. and Mackness , B. 2002 . Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip . Lancet , 359 : 763 – 764 .
   PubMed Web of Science ®Google Scholar
• Cole , T. B. , Walter , B. J. , Shih , D. M. , Tward , A. D. , Lusis , A. J. , Timchalk , C. , Richter , R. J. , Costa , L. G. and Furlong , C. E. 2005 . Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism . Pharmacogenet. Genom. , 15 : 589 – 598 .
   PubMed Web of Science ®Google Scholar
• Costa , L. and Manzo , L. 1995 . Biochemical markers of neurotoxicity: Research strategies and epidemiological applications . Toxicol. Lett. , 77 : 137 – 144 .
   PubMed Web of Science ®Google Scholar
• Costa , L. , Li , W. , Richter , R. , Shih , D. , Lusis , A. and Furlong , C. 1999 . The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism . Chem. Biol. Interact. , 119–120 : 429 – 438 .
   PubMed Web of Science ®Google Scholar
• Costa , L. G. , Cole , T. B. , Vitalone , A. and Furlong , C. E. 2005a . Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity . Clin. Chim. Acta , 352 : 37 – 47 .
   PubMed Web of Science ®Google Scholar
• Costa , L. G. , Vitalone , A. , Cole , T. B. and Furlong , C. E. 2005b . Modulation of paraoxonase (PON1) activity . Biochem. Pharmacol. , 69 : 541 – 550 .
   PubMed Web of Science ®Google Scholar
• Cowan , J. , Sinton , C. , Varley , A. , Wians , F. , Haley , R. and Munford , R. 2001 . Gene therapy to prevent organophosphate intoxication . Toxicol. Appl. Pharmacol. , 173 : 1 – 6 .
   PubMed Web of Science ®Google Scholar
• Cumming , J. 1999 . Understanding Parkinson's disease . J. Am. Med. Assoc. , 281 : 376 – 378 .
   Web of Science ®Google Scholar
• Davies , H. , Richter , R. , Keifer , M. , Broomfield , C. , Sowalla , J. and Furlong , C. 1996 . The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin . Nat. Genet. , 14 : 334 – 336 .
   PubMed Web of Science ®Google Scholar
• Deakin , S. P. and James , R. W. 2004 . Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1 . Clin. Sci. , 107 : 435 – 447 .
   PubMed Web of Science ®Google Scholar
• Deakin , S. , Leviev , I. , Nicaud , V. , Brulhart Meynet , M. , Tiret , L. and James , R. 2002 . Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families . J. Clin. Endocrinol. Metab. , 87 : 1268 – 1273 .
   PubMed Web of Science ®Google Scholar
• Eaton , D. L , Daroff , R. F , Autrup , H. , Bridges , J. , Buffler , P. , Costa , L. G. , Coyle , J. , McKhann , G. , Mobley , W. C. , Nadel , L. , Nubert , D. , Schulte-Hermann , R. and Spencer , P. S. 2008 . Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment . Crit. Rev. Toxicol. , 38 : 1 – 125 .
   PubMed Web of Science ®Google Scholar
• Ecobichon , D. and Stephens , D. 1973 . Perinatal development of human blood esterases . Clin. Pharmacol. Ther. , 14 : 41 – 47 .
   PubMed Web of Science ®Google Scholar
• Erlich , P. M. , Lunetta , K. L. , Cupples , L. A. , Huyck , M. , Green , R. C. , Baldwin , C. T. and Farrer , L. A. 2006 . Polymorphisms in the PON gene cluster are associated with Alzheimer disease . Hum. Mol. Genet. , 15 : 77 – 85 .
   PubMed Web of Science ®Google Scholar
• Eskenazi , B. , Harley , K. , Bradman , A. , Weltzien , E. , Jewell , N. P. , Barr , D. B. , Furlong , C. E. and Holland , N. T. 2004 . Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population . Environ. Health Perspect. , 112 : 1116 – 1124 .
   PubMed Web of Science ®Google Scholar
• Eskenazi , B. , Marks , A. R. , Bradman , A. , Harley , K. , Barr , D. B. , Johnson , C. , Morga , N. and Jewell , N. P. 2007 . Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children . Environ. Health Perspect. , 115 : 792 – 798 .
   PubMed Web of Science ®Google Scholar
• Fanella , S. , Harris , S. , Young , T. , Hanley , A. , Zinman , B. , Connelly , P. and Hegele , R. 2000 . Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations . Clin. Chem. Lab. Med. , 38 : 413 – 420 .
   PubMed Web of Science ®Google Scholar
• Feingold , K. , Memon , R. , Moser , A. and Grunfeld , C. 1998 . Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response . Atherosclerosis , 139 : 307 – 315 .
   PubMed Web of Science ®Google Scholar
• Fong , C. S. , Cheng , C. W. and Wu , R. M. 2005 . Pesticide exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease . Acta Neurol. Taiwan , 14 : 55 – 60 .
   PubMedGoogle Scholar
• Furlong, C. E. 2002. Comments on genetic and developmental variability of sensitivity to chlorpyrifos/chlorpyrifos oxon exposure as modulated by plasma paraoxonase (PON1). Comments provided to U.S. EPA SAP on Chlorpyrifos http://www.epa.gov/scipoly/sap/2002/june/chlorphyr.pdf
   Google Scholar
• Furlong , C. , Richter , R. , Seidel , S. , Costa , L. and Motulsky , A. 1989 . Spectrophotometric assay for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/amylesterase . Anal. Biochem. , 180 : 242 – 247 .
   PubMed Web of Science ®Google Scholar
• Furlong , C. , Li , W.-F. , Brophy , V. , Jarvik , P. , Richter , R. , Shih , D. , Lusis , A. and Costa , L. 2000a . The PON1 gene and detoxication . Neurotoxicology , 21 : 581 – 588 .
   PubMed Web of Science ®Google Scholar
• Furlong , C. , Richter , R. , Shih , D. , Lusis , A. , Alleva , E. and Costa , L. 2000b . Genetic and temporal determinants of pesticide sensitivity: Role of paraoxonase (PON1) . Neurotoxicology , 21 : 91 – 100 .
   PubMed Web of Science ®Google Scholar
• Furlong , C. E. , Cole , T. B. , Jarvik , G. P. , Pettan-Brewer , C. , Geiss , G. K. , Richter , R. J. , Shih , D. M. , Tward , A. D. , Lusis , A. J. and Costa , L. G. 2005 . Role of paraoxonase (PON1) status in pesticide sensitivity: Genetic and temporal determinants . Neurotoxicology , 26 : 651 – 659 .
   PubMed Web of Science ®Google Scholar
• Furlong , C. E. , Holland , N. , Richter , R. J. , Bradman , A. , Ho , A. and Eskenazi , B. 2006 . PON1 status of farm worker mothers and children as a predictor of organophosphate sensitivity . Pharmacogenet. Genom. , 16 : 183 – 190 .
   PubMed Web of Science ®Google Scholar
• Gamboa , R. , Zamora , J. , Rodriguez-Perez , J. M. , Fragoso , J. M. , Cardoso , G. , Posadas-Romero , C. and Vargas-Alarcon , G. 2006 . Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile . Exp. Mol. Pathol. , 80 : 85 – 90 .
   PubMed Web of Science ®Google Scholar
• Geldmacher-von Mallinckrodt , M. and Diepgen , T. 1988 . The human serum paraoxonase—Polymorphism and specificity . Toxicol. Environ. Chem. , 18 : 79 – 196 .
   Web of Science ®Google Scholar
• Gentry , P. R. , Hack , C. E. , Haber , L. , Maier , A. and Clewell , H. J. 2002 . An approach for the quantitative consideration of geneteic polymorphism data in chemical risk assessment: Examples with warfarin and parathion . Pharmacol. Sci. , 70 : 120 – 139 .
   Google Scholar
• Giles , W. H. , Croft , J. B. , Greenlund , K. J. , Ford , E. S. and Kittner , S. J. 2000 . Association between total homocysteine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Study Examination Survey . Am. Heart J. , 39 : 446 – 453 .
   Google Scholar
• Ginsberg , G. , Hattis , D. , Sonawane , B. , Russ , A. , Banati , P. , Kozlak , M. , Smolenski , S. and Goble , R. 2002 . Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature . Toxicol. Sci. , 66 : 185 – 200 .
   PubMed Web of Science ®Google Scholar
• Haber , L. T. , Maier , A. , Gentry , P. R. , Clewell , H. J. and Dourson , M. L. 2002 . Genetic polymorphisms in assessing interindividual variability in delivered dose . Regul. Pharmacol. , 35 : 177 – 197 .
   PubMed Web of Science ®Google Scholar
• Haley , R. , Billecke , S. and La Du , B. 1999 . Association of low PON1 Type Q (Type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans . Toxicol. Appl. Pharmacol. , 157 : 227 – 233 .
   PubMed Web of Science ®Google Scholar
• Hassett , C. , Richter , R. , Humbert , R. , Chapline , C. , Crabb , J. , Omiecinski , C. and Furlong , C. 1991 . Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence . Biochemistry , 30 : 10141 – 10149 .
   PubMed Web of Science ®Google Scholar
• He , X. M. , Zhang , Z. X. , Zhang , J. W. , Zhou , Y. T. , Tang , M. N. , Wu , C. B. and Hong , Z. 2006 . Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population . Chin. Med. J. , 119 : 1204 – 1209 .
   PubMed Web of Science ®Google Scholar
• Hegele , R. 1999 . Paraoxonase genes and disease . Ann. Med. , 31 : 217 – 224 .
   PubMed Web of Science ®Google Scholar
• Hegele , R. , Connelly , P. , Scherer , S. , Hanley , A. , Harris , S. , Tsui , L. and Zinman , B. 1997 . Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus . J. Clin. Endocrinol. Metab. , 82 : 3373 – 3377 .
   PubMed Web of Science ®Google Scholar
• Herrmann , S. , Blanc , H. , Poirier , O. , Arveiler , D. , Luc , G. , Evans , A. , Marques-Vidal , P. , Bard , J. and Cambien , F. 1996 . The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study . Atherosclerosis , 126 : 299 – 303 .
   PubMed Web of Science ®Google Scholar
• Holland , N. , Furlong , C. , Bastaki , M. , Richter , R. , Bradman , A. , Huen , K. , Beckman , K. and Eskenazi , B. 2006 . Paraoxonase polymorphisms, haplotypes and enzyme activity in Latino mothers and newborns . Environ. Health Perspect. , 114 : 985 – 991 .
   PubMed Web of Science ®Google Scholar
• Hong , S. , Song , J. , Min , W. and Kim , J. 2001 . Genetic variations of the paraoxonase gene in patients with coronary artery disease . Clin. Biochem. , 34 : 475 – 481 .
   PubMed Web of Science ®Google Scholar
• Huff , R. , Corcoran , J. , Anderson , J. and Abou-Donia , M. 1994 . Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum . J. Pharmacol. Exp. Ther. , 269 : 329 – 335 .
   PubMed Web of Science ®Google Scholar
• Humbert , R. , Adler , D. , Disteche , C. , Hassett , C. , Omiecinski , C. and Furlong , C. 1993 . The molecular basis of the human serum paraoxonase activity polymorphism . Nat. Genet. , 3 : 73 – 76 .
   PubMed Web of Science ®Google Scholar
• Ikeda , T. , Obayashi , H. , Hasegawa , G. , Nakamura , N. , Yoshikawa , T. , Imamura , Y. , Koizumi , K. and Kinoshita , S. 2001 . Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration . Am. J. Ophthalmol. , 132 : 191 – 195 .
   PubMed Web of Science ®Google Scholar
• Imai , Y. , Morita , H. , Kurihara , H. , Sugiyama , T. , Kato , N. , Ebihara , A. , Hamada , C. , Kurihara , Y. , Shindo , T. , Oh-Hashi , Y. and Yazaki , Y. 2000 . Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases . Atherosclerosis , 149 : 435 – 442 .
   PubMed Web of Science ®Google Scholar
• Inoue , M. , Suehiro , T. , Nakamura , T. , Ikeda , Y. , Kumon , Y. and Hashimoto , K. 2000 . Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with Type 2 diabetes . Metabolism , 49 : 1400 – 1405 .
   PubMed Web of Science ®Google Scholar
• Jakubowski , H. , Ambrosius , W. and Pratt , H. 2001 . Genetic determinants of homocysteine thiolactonase activity in humans: Implications for atherosclerosis . FEBS Lett. , 491 : 35 – 39 .
   PubMed Web of Science ®Google Scholar
• James , R. , Leviev , I. and Righetti , A. 2000 . Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease . Circulation , 101 : 2252 – 2257 .
   PubMed Web of Science ®Google Scholar
• Jarvik , G. , Rozek , L. , Brophy , V. , Hatsukami , T. , Richter , R. , Schellenberg , G. and Furlong , C. 2000 . Paraoxonase (PON1) phenotype is a better predictor of vascular disease that is PON1192 or PON155 genotype . Arterioscler. Thomb. Vasc. Biol. , 20 : 2441 – 2447 .
   PubMed Web of Science ®Google Scholar
• Jokanovic , M. , Kosanovic , M. and Maksimovic , M. 1996 . Interaction of organophosphorus compounds with carboxylesterases in the rat . Arch. Toxicol. , 70 : 444 – 450 .
   PubMed Web of Science ®Google Scholar
• Josse , D. , Lockridge , O. , Xie , W. , Bartels , C. , Schopfer , L. and Masson , P. 2001 . The active site of human paraoxonase (PON1) . J. Appl. Toxicol. , 21 : S7 – S11 .
   PubMed Web of Science ®Google Scholar
• Kao , Y. , Donaghue , K. , Chan , A. , Bennets , B. , Knight , J. and Silink , M. 2002 . Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes . Diabetic Med. , 19 : 212 – 215 .
   PubMed Web of Science ®Google Scholar
• Karanth , S. and Pope , C. 2000 . Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats . Toxicol. Sci. , 58 : 282 – 289 .
   PubMed Web of Science ®Google Scholar
• Kerkeni , M. , Addad , F. , Chauffert , M. , Chuniaud , L. , Miled , A. , Trivin , F. and Maaroufi , K. 2006 . Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease . Clin. Biochem. , 39 : 821 – 825 .
   PubMed Web of Science ®Google Scholar
• Kleemola , P. , Freese , R. , Juahiainen , M. , Pahlman , R. , Alfthan , G. and Mutanen , M. 2002 . Dietary determinants of serum paraoxonase activity in health humans . Atherosclerosis , 160 : 425 – 432 .
   PubMed Web of Science ®Google Scholar
• Kondo , I. and Yamamoto , M. 1998 . Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease . Brain Res. , 806 : 271 – 273 .
   PubMed Web of Science ®Google Scholar
• La Du , B. , Aviram , M. , Billecke , S. , Navab , M. , Primo-Parmo , S. , Sorenson , R. and Standiford , T. 1999 . On the physiological role(s) of the paraoxonases . Chem. Biol. Interact. , 120 : 379 – 388 .
   Google Scholar
• La Du , B. , Billecke , S. , Hsu , C. , Haley , R. and Broomfield , C. 2001 . Serum paraoxonase (PON1) isozymes: The quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals . Drug Metab. Dispos. , 29 : 566 – 569 .
   PubMed Web of Science ®Google Scholar
• Lassiter , T. , Padilla , S. , Mortensen , S. , Chanda , S. , Moser , V. and Barone , S. 1998 . Gestational exposure to chlorpyrifos: Apparent protection of the fetus? . Toxicol. Appl. Pharmacol. , 152 : 56 – 65 .
   PubMed Web of Science ®Google Scholar
• Le Couteur , D. , McLean , A. , Taylor , M. , Woodham , B. and Board , P. 1999 . Pesticides and Parkinson's disease . Biomed. Pharmacother. , 53 : 122 – 130 .
   PubMed Web of Science ®Google Scholar
• Leus , F. , Zwart , M. , Kastelein , J. and Voorbij , H. 2001 . PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients . Atherosclerosis , 154 : 641 – 649 .
   PubMed Web of Science ®Google Scholar
• Leviev , I. and James , R. 2000 . Promoter polymorphisms of the human paraoxonase PON1 gene and serum paraoxonase activities and concentrations . Arterioscler. Thromb. Vasc, Biol. , 20 : 516 – 521 .
   PubMed Web of Science ®Google Scholar
• Leviev , I. , Negro , F. and James , R. 1997 . Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism . Arterioscler. Thromb. Vasc. Biol. , 17 : 2935 – 2939 .
   PubMed Web of Science ®Google Scholar
• Leviev , I. , Righetti , A. and James , R. 2001 . Paraoxonase promoter polymorphism T(−107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease . J. Mol. Med. , 79 : 457 – 463 .
   PubMed Web of Science ®Google Scholar
• Leviev , I. , Poirier , O. , Nicaud , V. , Evans , A. , Kee , F. , Arveiler , D. , Morrisson , C. , Cambien , F. and James , R. 2002 . High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients . Atherosclerosis , 161 : 463 – 467 .
   PubMed Web of Science ®Google Scholar
• Li , W. , Furlong , C. and Costa , L. 1995 . Paraoxonase protects against chlorpyrifos toxicity in mice . Toxicol. Lett. , 76 : 219 – 226 .
   PubMed Web of Science ®Google Scholar
• Li , W. , Costa , L. , Richter , R. , Hagen , T. , Shih , D. , Tward , A. , Lusis , A. and Furlong , C. 2000 . Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds . Pharmacogenetics , 10 : 767 – 779 .
   PubMedGoogle Scholar
• Li , W. , Pan , M. H. , Chung , M. C. , Ho , C. K. and Chuang , H. Y. 2006 . Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes . Environ. Health Perspect. , 114 : 1233 – 1236 .
   PubMed Web of Science ®Google Scholar
• Liu , Y. J. , Huang , P. L. , Chang , Y. F. , Chen , Y. H. , Chiou , Y. H. , Xu , Z. L. and Wong , R. H. 2006 . GSTP1 genetic polymorphism is associated with a higher risk of DNA damage in pesticide-exposed fruit growers . Cancer Epidemiol. Biomarkers Prev. , 15 : 659 – 666 .
   PubMed Web of Science ®Google Scholar
• Mackness , B. , Mackness , M. , Arrol , S. , Turkie , W. and Durrington , P. 1997 . Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon . Br. J. Pharmacol. , 122 : 265 – 268 .
   PubMed Web of Science ®Google Scholar
• Mackness , B. , Mackness , M. , Arrol , S. , Turkie , W. , Julier , K. , Abuasha , B. , Miller , J. , Boulton , J. and Durrington , P. 1998 . Serum paraoxonase (PON1)55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus . Atherosclerosis , 139 : 341 – 349 .
   PubMed Web of Science ®Google Scholar
• Mackness , M. , Durrington , P. , Ayub , A. and Mackness , B. 1999 . Low serum paraoxonase: A risk factor for atherosclerotic disease? . Chem. Biol. Interact. , 120 : 389 – 397 .
   Google Scholar
• Mackness , B. , Mackness , M. , Durrington , P. , Arrol , S. , Evans , A. , McMaster , D. , Ferrieres , J. , Ruidavets , J. , Williams , N. and Howard , A. 2000 . Paraoxonase activity in two health populations with differing rates of coronary heart disease . Eur. J. Clin. Invest. , 30 : 4 – 10 .
   PubMed Web of Science ®Google Scholar
• Mackness , M. , Bouiller , A. , Hennuyer , N. , Mackness , B. , Hall , M. , Tailleux , A. , Duriez , P. , Delfly , B. , Durrington , P. , Fruchart , J. , Duverger , N. , Caillaud , J. and Castro , G. 2000 . Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits . Biochem. Biophys. Res. Commun. , 269 : 232 – 236 .
   PubMed Web of Science ®Google Scholar
• Mackness , B. , Davies , G. , Turkie , W. , Lee , E. , Roberts , D. , Hill , E. , Roberts , C. , Durrington , P. and Mackness , M. 2001 . Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype? . Arterioscler. Thromb. Vasc. Biol. , 21 : 1451 – 1457 .
   PubMed Web of Science ®Google Scholar
• Marra , M. , Marchegiani , F. , Antonicelli , R. , Sirolla , C. , Spazzafumo , L. , Olivieri , F. , Franceschi , C. , Testa , R. , Paolisso , G. , James , R. W. , Boemi , M. and Parati , G. 2006 . The PON1192RR genotype is associated with a higher prevalence of arterial hypertension . J. Hypertens. , 24 : 1293 – 1298 .
   PubMed Web of Science ®Google Scholar
• Mastorikou , M. , Mackness , M. and Mackness , B. 2006 . Defective metabolism of oxidized phospholipids by HDL from people with type 2 diabetes . Diabetes , 55 : 3099 – 3103 .
   PubMed Web of Science ®Google Scholar
• Meuller , R. , Hornung , S. , Furlong , C. , Anderson , J. , Giblett , E. and Motulsky , A. 1983 . Plasma paraoxonase polymorphism: A new enzyme assay, population, family, biochemical and linkage studies . Am. J. Hum. Genet. , 35 : 393 – 408 .
   PubMed Web of Science ®Google Scholar
• Mochizuki , H. , Scherer , S. , Xi , T. , Nickle , D. , Majer , M. , Huizenga , J. , Tsui , L. and Prochazka , M. 1998 . PON2 gene at 7q21.3: Cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence . Gene , 213 : 149 – 157 .
   PubMed Web of Science ®Google Scholar
• Mortensen , S. , Chanda , S. , Hooper , M. and Padilla , S. 1996 . Maturational differences in chlorpyrifos-oxonase activity may contribut to age-related sensitivity to chlorpyrifos . J. Biochem. Toxicol. , 11 : 279 – 287 .
   PubMedGoogle Scholar
• Moser , V. , Chanda , S. , Mortensen , S. and Padilla , S. 1998 . Age and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities . Toxicol. Sci. , 46 : 211 – 222 .
   PubMed Web of Science ®Google Scholar
• Mueller , R. , Hornung , S. , Furlong , C. , Anderson , J. , Giblett , E. and Motulsky , A. 1983 . Plasma paraoxonase polymorphism: A new enzyme assay, population, family, biochemical and linkage studies . Am. J. Hum. Genet. , 35 : 393 – 408 .
   PubMed Web of Science ®Google Scholar
• Mutch , E. , Daly , A. K. and Williams , F. M. 2007 . The relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver . Drug Metab. Dispos. , 35 : 315 – 320 .
   PubMed Web of Science ®Google Scholar
• Needham , L L. 2005 . Assessing exposure to organophosphorus pesticides by biomonitoring in epidemiologic studies of birth outcomes . Environ. Health Perspect. , 113 : 494 – 498 .
   PubMed Web of Science ®Google Scholar
• Nishio , E. and Watanabe , Y. 1997 . Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiol . Biochem. Biophys. Res. Commun. , 236 : 289 – 293 .
   PubMed Web of Science ®Google Scholar
• Ng , C. J. , Wadleigh , D. J. , Gangopadhyay , A. , Hama , S. , Grijalva , V. R. , Navab , M. , Fogelman , A. M. and Reddy , S. T. 2001 . Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein . J. Biol. Chem. , 276 : 44444 – 44449 .
   PubMed Web of Science ®Google Scholar
• Ng , C. J. , Shih , D. M. , Hama , S. Y. , Villa , N. , Navab , M. and Reddy , S. T. 2005 . The paraoxonase gene family and atherosclerosis . Free Radical Biol. Med. , 38 : 153 – 163 .
   PubMed Web of Science ®Google Scholar
• Odawara , M. , Tachi , Y. and Yamashita , K. 1997 . Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetic patients . J. Clin. Endocrinol. Metab. , 82 : 2257 – 2260 .
   PubMed Web of Science ®Google Scholar
• O'Leary , K. A. , Edwards , R. J. , Town , M. M. and Boobis , A. R. 2005 . Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: Consequences for risk from exposure to diazinon . Pharmacogenet. Genom. , 15 : 51 – 60 .
   PubMedGoogle Scholar
• Padilla , S. , Buzzard , J. and Moser , V. 2000 . Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos . Neurotoxicology , 21 : 49 – 56 .
   PubMed Web of Science ®Google Scholar
• Paragh , G. , Seres , I. , Balogh , Z. , Varga , Z. , Karpati , I. , Matyus , J. , Ujhelyi , L. and Kakuk , G. 1998 . The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia . Nephron , 80 : 166 – 170 .
   PubMed Web of Science ®Google Scholar
• Patel , B. , Mackness , M. , Harty , D. , Arrol , S. , Boot-Handford , R. and Durrington , P. 1990 . Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat . Biochim. Biophys. Acta , 1035 : 113 – 116 .
   PubMed Web of Science ®Google Scholar
• Pinizzotto , M. , Castillo , E. , Fiaux , M. , Temler , E. , Gaillard , R. and Ruiz , J. 2001 . Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes . Diabetologia , 44 : 104 – 107 .
   PubMed Web of Science ®Google Scholar
• Pope , C. N. 1999 . Organophosphate pesticides: Do they all have the same mechanisms of toxicity? . J. Toxicol. Environ. Health B , 2 : 161 – 181 .
   PubMed Web of Science ®Google Scholar
• Povey , A. C. , Mackness , M. I. , Durrington , P. N. , Dippnall , M. , Smith , A. E. , Mackness , B. and Cherry , N. M. 2005 . Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep . Occup. Med. , 55 : 282 – 286 .
   Google Scholar
• Primo-Parmo , S. , Sorenson , R. , Teiber , J. and La Du , B. 1996 . The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family . Genomics , 33 : 498 – 507 .
   PubMed Web of Science ®Google Scholar
• Rao , M. N. , Marmillot , P. , Gong , M. , Palmer , D. A. , Seeff , L B. , Strader , D. B. and Laksham , M. R . 2003 . Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans . Metabolism , 52 : 1287 – 1294 .
   PubMed Web of Science ®Google Scholar
• Rauh , V. A. , Garfinkel , R. , Perera , F P. , Andrews , H. F. , Hoepner , L. , Barr , D. B. , Whitehead , R. , Tang , D. and Whyatt , R. W. 2006 . Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children . Pediatrics , 118 : 1845 – 1859 .
   PubMed Web of Science ®Google Scholar
• Richter , R. and Furlong , C. 1999 . Determination of paraoxonase (PON1) status requires more than genotyping . Pharmacogenetics , 9 : 745 – 753 .
   PubMedGoogle Scholar
• Rojas-Garcia , A. E. , Solis-Heredia , M. J. , Pina-Guzman , B. , Vega , L. , Lopez-Carrillo , L. and Quintanilla-Vega , B. 2005 . Genetic polymorphisms and activity of PON1 in a Mexican population . Toxicol. Appl. Pharmacol. , 205 : 282 – 289 .
   PubMed Web of Science ®Google Scholar
• Roy , A. , Loke , D. , Saha , N. , Viegas , O. , Tay , J. and Ratnam , S. 1994 . Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study . Gynecol. Obstet. Invest. , 38 : 10 – 13 .
   PubMed Web of Science ®Google Scholar
• Salonen , J. , Malin , R. , Tuornainen , T. , Nyyssonen , K. , Lakka , T. and Lehtimaki , T. 1999 . Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study . Br. Med. J. , 319 : 487 – 489 .
   PubMed Web of Science ®Google Scholar
• Sanghera , D. , Saha , N. , Aston , C. and Kamboth , M. 1997 . Genetic polymorphism of paraoxonase and the risk of coronary heart disease . Arterioscler. Thromb. Vasc. Biol. , 17 : 1067 – 1073 .
   PubMed Web of Science ®Google Scholar
• Sanghera , D. , Saha , N. and Kamboh , M. 1998 . The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese . Atherosclerosis , 136 : 217 – 223 .
   PubMed Web of Science ®Google Scholar
• Schiavon , R. , De Fanti , E. , Giavarina , D. , Biasioli , S. , Cavalcanti , G. and Guidi , G. 1996 . Serum paraoxonase activity is decreased in uremic patients . Clin. Chim. Acta , 247 : 71 – 80 .
   PubMed Web of Science ®Google Scholar
• Selhub , J. 1999 . Homocysteine metabolism . Annu. Rev. Nutr. , 19 : 217 – 246 .
   PubMed Web of Science ®Google Scholar
• Searles Nielsen , S. , Mueller , B. A. , DeRoos , A. J. , Viernes , H. M. , Farin , F. M. and Checkoway , H. 2005 . Risk of brain tumors in children and susceptibility to organophosphorus insecticides: The potential role of paraoxonase (PON1) . Environ. Health Perspect. , 113 : 909 – 913 .
   PubMed Web of Science ®Google Scholar
• Sen-Banerjee , S. , Siles , X. and Campos , H. 2000 . Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction . Arterioscler. Thromb. Vasc. Biol. , 20 : 2120 – 2126 .
   PubMed Web of Science ®Google Scholar
• Senti , M. , Tomas , M. , Anglada , R. , Elosua , R. , Marrugat , J. , Covas , M. I. and Fito , M. 2003 . Inter-relationship of smoking, paraoxonase activity, and leisure time physical activity: A population-based study . Eur. J. Int. Med. , 14 : 78 – 184 .
   Google Scholar
• Serrato , M. and Marian , A. 1995 . A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease . J. Clin. Invest. , 96 : 3005 – 3008 .
   PubMed Web of Science ®Google Scholar
• Sirivarasai , J. , Kaojarern , S. , Yoovathaworn , K. and Sura , T. 2007 . Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects . Chem. Biol. Interact. , 168 : 184 – 192 .
   PubMed Web of Science ®Google Scholar
• Shih , D. , Gu , L. and Xia , Y. 1998 . Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis . Nature , 394 : 284 – 287 .
   PubMed Web of Science ®Google Scholar
• Shih , D. , Xia , Y. , Wang , X. , Miller , E. , Castellani , L. , Subbanagounder , G. , Cheroutre , H. , Faull , K. , Berliner , J. , Witztum , J. and Lusis , A. 2000 . Combined serum paraoxonase knockout/alipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis . J. Biol. Chem. , 275 : 17527 – 17535 .
   PubMed Web of Science ®Google Scholar
• Smolen , A. , Eckerson , H. , Gan , K. , Hailat , N. and La Du , B. 1991 . Characteristics of the genetically determined polymorphic forms of human serum paraoxonase/arylesterase . Drug Metab. Dispos. , 19 : 107 – 112 .
   PubMed Web of Science ®Google Scholar
• Sorenson , R. , Bisgaier , C. , Aviram , M. , Billecke , S. and La Du , B. 1999 . Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with high density lipoproteins by binding phospholipids: Apolipoprotein A-1 stabilizes activity . Atheroscler. Thromb. Vasc. Biol. , 19 : 2214 – 2225 .
   PubMed Web of Science ®Google Scholar
• Suehiro , T. , Nakatichi , Y. , Yamarnoto , M. , Arii , K. , Itoh , H. , Hamashige , N. and Hashimoto , K. 1996 . Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease . Int. J. Cardiol. , 15 : 69 – 73 .
   Google Scholar
• Suehiro , T. , Nakamura , T. , Inoue , M. , Shiinoki , T. , Ikeda , Y. , Kumon , Y. , Shindo , M. , Tanaka , H. and Hashimoto , K. 2000 . A polymorphism up-stream from the human paraoxonase (PON1) gene and its association with PON1 expression . Atherosclerosis , 150 : 295 – 298 .
   PubMed Web of Science ®Google Scholar
• Sutherland , W. , Walker , R. , de Jong , S. , van Rij , A. , Phillips , V. and Walker , H. 1999 . Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat . Arterioscler. Thromb. Vasc. Biol. , 19 : 1340 – 1347 .
   PubMed Web of Science ®Google Scholar
• Taylor , M. , Couteur , D. , Mellick , G. and Board , P. 2000 . Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population . J. Neural Transmission , 107 : 979 – 983 .
   PubMed Web of Science ®Google Scholar
• Tripi , L. M. , Manzi , S. , Chen , Q. , Kenney , M. , Shaw , P. , Kao , A. , Bontempo , F. , Kammerer , C. and Kamboh , M. I. 2006 . Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus . Arthritis Rheum. , 54 : 1928 – 1939 .
   PubMed Web of Science ®Google Scholar
• Turban , S. , Fuentes , F. , Ferlic , L. , Brugada , R. , Gotto , A.M. , Ballantyne , C. M. and Marian , A. J. 2001 . A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression, and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin . Atheroschlerosis , 154 : 633 – 640 .
   PubMed Web of Science ®Google Scholar
• Vitarius , J. and Sultatos , L. 1994 . Kinetic mechanism of the detoxification of the organophosphate paraoxon by human serum A-esterase . Drug Metab. Dispos. , 22 : 472 – 478 .
   PubMed Web of Science ®Google Scholar
• Vitarius , J. and Sultatos , L. 1995 . The role of calcium in the hydrolysis of the organophosphate paraoxon by human serum A-esterase . Life Sci. , 56 : 125 – 134 .
   PubMed Web of Science ®Google Scholar
• Voetsch , B. , Benke , K. , Damasceno , B. , Siqueira , L. and Loscalzo , J. 2002 . Paraoxonase 192 Gln →Arg polymorphism. An independent risk factor for nonfatal arterial ischemic stroke among young adults . Stroke , 33 : 1459 – 1464 .
   PubMed Web of Science ®Google Scholar
• Weitman , S. , Vodicnik , M. and Lech , J. 1983 . Influence of pregnancy on parathion toxicity and disposition . Toxicol. Appl. Pharmacol. , 71 : 215 – 224 .
   PubMed Web of Science ®Google Scholar
• Whyatt , R. M. , Camann , D. , Perera , F. P. , Rauh , V. A. , Tang , D. , Kinney , P. L. , Garfinkel , R. , Andrews , H. , Hoepner , L. and Barr , D. B. 2005 . Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth . Toxicol. Appl. Pharmacol. , 206 : 246 – 254 .
   PubMed Web of Science ®Google Scholar
• Wolff , M. S. , Engel , S. , Berkowitz , G. , Teitelbaum , S. , Siskind , J. , Barr , D. B. and Wetmur , J. 2007 . Prenatal pesticide and PCB exposures and birth outcomes . Pediatr. Res. , 61 : 243 – 250 .
   PubMed Web of Science ®Google Scholar
• Yuknavage , K. , Fenske , R. , Kalman , D. , Keifer , M. and Furlong , C. 1997 . The effect of organophosphate pesticide dermal contamination on field cholinesterase biomonitoring, results of capillary samples . J. Toxicol. Environ. Health , 51 : 35 – 55 .
   PubMed Web of Science ®Google Scholar
• Zama , T. , Murata , M. , Matsubara , Y. , Kawano , K. , Aoki , N. , Yoshino , H. , Watanbe , G. , Ishikawa , K. and Ikeda , Y. 1997 . A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese . Arterioscler. Thromb. Vasc. Biol. , 17 : 3565 – 3569 .
   PubMed Web of Science ®Google Scholar
• Zech , R. and Zurcher , K. 1974 . Organophosphate splitting enzymes in different mammals . Comp. Biochem. Physiol. , 48B : 427 – 433 .
   Google Scholar
• Zintzaras , E. and Hadjigeorgiou , G. M. 2004 . Association of paraoxon 1 gene polymorphisms with risk of Parkinson's disease: A meta-analysis . J. Hum. Genet. , 49 : 474 – 481 .
   PubMed Web of Science ®Google Scholar